a-Pyrrolidino-2-phenylacetophenone hydrochloride CAS: 27590-61-0

CAS NO: 27590-61-0
Our products are for experimental study only
a-Pyrrolidino-2-phenylacetophenone hydrochloride
Chemical Name: Ethanone,1,2-diphenyl-2-(1-pyrrolidinyl)-, hydrochloride (1:1)
Molecular Formula: C18H20ClNO
Formula Weight: 301.8105
CAS No.: 27590-61-0
Description Review
Description
Our products are for experimental study only

a-Pyrrolidino-2-phenylacetophenone hydrochloride (CAS: 27590-61-0) is a synthetic compound that is also known as alpha-PVP or flakka. The drug belongs to the class of cathinones, which are stimulant drugs similar in structure and effect to amphetamines. Alpha-PVP has become popular in recent years as a recreational drug due to its potent stimulant effects, but its use has been associated with numerous adverse effects.

Chemical name

The chemical name for alpha-PVP is 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one hydrochloride.

Molecular formula

The molecular formula for alpha-PVP is C15H21NO.HCl.

Formula weight

The formula weight for alpha-PVP hydrochloride is 275.80 g/mol.

CAS No.

The CAS number for alpha-PVP hydrochloride is 27590-61-0.

Top Ten Keywords from Google and Synonyms

  1. Flakka
  2. Designer drugs
  3. Synthetic cathinones
  4. Bath salts
  5. Research chemicals
  6. Party drugs
  7. Legal high
  8. Stimulants
  9. Recreational drugs
  10. Novel psychoactive substances (NPS)

Health Benefits of This Product

Alpha-PVP has no known health benefits and is not approved for medical use by any regulatory agency. It is classified as a research chemical or novel psychoactive substance and is primarily used for recreational purposes.

Potential Effects

Alpha-PVP is a potent stimulant that can produce feelings of euphoria, increased energy, and heightened alertness. The drug can induce intense cravings, leading to compulsive redosing and potentially increasing the risk of overdose. At higher doses, alpha-PVP can cause agitation, paranoia, hallucinations, and even psychosis. The onset of effects is rapid, with peak effects occurring within 20-30 minutes of ingestion. The duration of effects can last up to several hours.

Product Mechanism

Alpha-PVP works by increasing the activity of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. These neurotransmitters are responsible for regulating mood, energy levels, and arousal. Alpha-PVP enhances the release and reuptake inhibition of these neurotransmitters, resulting in increased stimulation and euphoria.

Safety

Alpha-PVP has not been approved for medical use by any regulatory agency and is classified as a research chemical or novel psychoactive substance. The drug's potency and unpredictable effects make it potentially dangerous, increasing the risk of overdose and severe adverse effects such as seizures or cardiac arrest. Additionally, alpha-PVP can lead to addiction and long-term mental health problems, including anxiety, depression, and psychosis.

Side Effects

Common side effects of alpha-PVP include restlessness, agitation, anxiety, insomnia, increased heart rate and blood pressure, sweating, and tremors. At higher doses, users may experience hallucinations, paranoia, and even psychosis. Overdose can lead to severe respiratory depression, seizures, coma, and even death.

Dosing Information

Due to the lack of regulation and standardization, dosing information for alpha-PVP is highly variable and often inaccurate. Users should exercise caution when using this drug and start with small doses to gauge their tolerance. A typical dose of alpha-PVP ranges from 5-20 mg, with a maximum daily dose of 50 mg. However, due to the drug's high potency, even small amounts can cause adverse effects and potential overdose.

Conclusion

Alpha-PVP is a potent stimulant drug that belongs to the class of synthetic cathinones. The drug has gained popularity in recent years among recreational drug users due to its intense stimulant effects. However, the drug's potency and unpredictable effects increase the risk of adverse effects, including addiction, long-term mental health problems, and potentially fatal overdose. Therefore, it is essential to exercise caution when using this drug and seek professional help if experiencing adverse effects or symptoms of overdose

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code